Show simple item record

dc.contributor.authorJohnston, SRD
dc.date.accessioned2018-02-15T12:21:19Z
dc.date.issued2017-11
dc.identifier.citationClinical oncology (Royal College of Radiologists (Great Britain)), 2017, 29 (11), pp. 703 - 706
dc.identifier.issn0936-6555
dc.identifier.urihttps://repository.icr.ac.uk/handle/internal/1111
dc.identifier.eissn1433-2981
dc.identifier.doi10.1016/j.clon.2017.06.016
dc.formatPrint-Electronic
dc.format.extent703 - 706
dc.languageeng
dc.language.isoeng
dc.titleAre Cyclin-dependent Kinase 4/6 Inhibitors Needed for all Oestrogen Receptor-positive Metastatic Breast Cancers?
dc.typeJournal Article
dcterms.dateAccepted2017-06-19
rioxxterms.versionofrecord10.1016/j.clon.2017.06.016
rioxxterms.licenseref.startdate2017-11
rioxxterms.typeJournal Article/Review
dc.relation.isPartOfClinical oncology (Royal College of Radiologists (Great Britain))
pubs.issue11
pubs.notesNot known
pubs.organisational-group/ICR
pubs.organisational-group/ICR/Primary Group
pubs.organisational-group/ICR/Primary Group/ICR Divisions
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Breast Cancer Research
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Breast Cancer Research/Endocrine Therapy Resistance
pubs.organisational-group/ICR/Primary Group/Royal Marsden Clinical Units
pubs.organisational-group/ICR
pubs.organisational-group/ICR/Primary Group
pubs.organisational-group/ICR/Primary Group/ICR Divisions
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Breast Cancer Research
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Breast Cancer Research/Endocrine Therapy Resistance
pubs.organisational-group/ICR/Primary Group/Royal Marsden Clinical Units
pubs.publication-statusPublished
pubs.volume29
pubs.embargo.termsNot known
icr.researchteamEndocrine Therapy Resistance
dc.contributor.icrauthorJohnston, Stephen
dc.contributor.icrauthorMarsden,


Files in this item

Thumbnail

This item appears in the following collection(s)

Show simple item record